ReviewJournal of thoracic disease2022

Immune checkpoint inhibitor-related interstitial lung disease in patients with advanced non-small cell lung cancer: systematic review of characteristics, incidence, risk factors, and management.

Seohyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.